NIH-funded research Sbir 2 grant

Understanding how transplanted cells respond in the body for diabetes treatment

Official title: Monitoring graft responses to the transplant niche in allogeneic cell replacement therapy

Funded at Minutia, INC. · NIH-10931682 · Data updated 2026-11-12

This study is looking at how transplanted cells for people with Type 1 Diabetes work with the immune system and the body, so we can find better ways to keep those cells healthy and safe from stress, helping them work better for you.

More Transplant research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionMinutia, INC.
NIH-funded
Lab location1 site (Oakland, United States)
Project startSeptember 6, 2021
Project endAugust 30, 2025
Funding year2024
Award (this year)$870,000
NIH project number5R44DK130034-03
Project IDNIH-10931682 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals with Type 1 Diabetes who are considering or have undergone cell transplantation.

Less likely to help

Patients with Type 2 Diabetes or those who are not candidates for cell transplantation may not benefit from this research.

What this research studies

This research investigates how transplanted cells for Type 1 Diabetes patients interact with the immune system and the surrounding environment in the body. It aims to develop methods to monitor the health of these transplanted cells and identify when they are under stress from inflammation. By understanding these responses, the researchers hope to create targeted therapies that can protect the transplanted cells and improve their chances of success. The approach includes using advanced biosensing techniques to track the graft's condition in real-time.

Why it matters

Potential benefit: If successful, this research could lead to improved outcomes for patients receiving cell transplants for Type 1 Diabetes, potentially reducing the need for multiple transplants.

How similar studies have gone: Previous research has shown promise in using biosensing techniques to monitor graft health, indicating that this approach could be effective.

Where this research is happening

  • Minutia, INC.
    Oakland, United States
    Active

Researchers

  • Principal investigator: Digovich, Catherine — Minutia, INC.
  • Study coordinator: Digovich, Catherine

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.